Polycystic Ovarian Syndrome. Ovarian dysfunction, unspecified
Conditions
Interventions
Patients with dignosis of PCOD under treatment with myoinositol (powder) 4 gram daily for three months and primary and secondary outcome measure before and after reatment.
Treatment - Drugs
Patients with dignosis of PCOD under treatment with myoinositol (powder) 4 gram daily for three months and primary and secondary outcome measure before and after reatment
Sponsors
Vice chancellor for research, Shahid Beheshti University of Medical Science
Healthparsian. com
Eligibility
Sex/Gender
Female
Age
20 Years to 40 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: women who were between 20 and 40 years old, and had PCOS diagnosed by a gynecologist. Exclusion criteria: patients who were diagnosed with Cushing syndrome, congenital adrenal hyperplasia, hyperprolactinemia, hypothyroidism, hyperthyroidism, androgen secreting tumor; medications known to affect metabolic parameters, such as metformin and corticosteroids.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fasting glucose. Timepoint: Before intervention and three months after treatment. Method of measurement: Blood serum.;Fasting insulin. Timepoint: Before intervention and three months after treatment. Method of measurement: Blood serum.;HOMA IR. Timepoint: Before intervention and three months after treatment. Method of measurement: Calculation by formola. | — |
Secondary
| Measure | Time frame |
|---|---|
| Weight. Timepoint: Before intervention and three months after treatment. Method of measurement: Balance.;Height. Timepoint: Before intervention and three months after treatment. Method of measurement: Meter.;Body Mass Index. Timepoint: Before intervention and three months after treatment. Method of measurement: Formola.;Low density lipoprotein. Timepoint: Before intervention and three months after treatment. Method of measurement: Blood serum.;High density lipoprotein. Timepoint: Before intervention and two months after vitamin D injection. Method of measurement: Blood serum.;Free testosterone. Timepoint: Before intervention and two months after vitamin D injection. Method of measurement: Blood serum.;Dehydoepiandrasteione. Timepoint: Before intervention and two months after vitamin D injection. Method of measurement: Blood serum.;Triglyceride. Timepoint: Before intervention and two months after vitamin D injection. Method of measurement: Blood serum. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Saghar salehpour
Infertility & Reproductive Health Research Centre - Shahid Beheshti of Medical Science
Outcome results
None listed